Sorafenib, marketed under the brand name Nexavar, is an oral multikinase inhibitor used to treat various types of cancer. It works by targeting and inhibiting multiple kinases involved in tumor cell proliferation and angiogenesis. This makes it effective in slowing down or stopping the growth of cancer cells.
